DailyDirt: Playing With Biological Fire?

Bleeding Edge

from the urls-we-dig-up dept

There was a time when, if something was viral, it was almost certainly a bad thing. (Now, being viral could mean you’re going to be the next Justin Bieber.) With current biotech research, the end of common diseases could be at hand or we could be launching ourselves into the next era of viciously untreatable illnesses that we’ve had a hand in creating. Hopefully, we’re not going to be living out a bad sci-fi movie plot anytime soon. Here are just a few potential precursors to the apocalypse, though.

• Oxford University researchers are testing a flu vaccine that will work on all known strains by targeting proteins in the virus that are common to all flu variants. But what happens 28 days later…? [url]
• The release of sterile transgenic mosquitoes in Malaysia was aimed at fighting dengue by reducing mosquito populations. This actually isn’t the first time these mosquitoes were tested in the field… and I, for one, welcome our new insect overlords. [url]
• Synthetic biology is a growing field now that the guidelines from the Presidential Commission for the Study of Bioethical Issues (PCSBI) are out. “Scientists can’t be so naive to think there won’t be a possibility of bad things happening, but I think the public will grow to accept synthetic biology if we’re able to talk about all of the great things that can be done with it.” [url]
• To discover more biotech stuff, check out what’s roaming around in the StumbleUpon jungle. [url]  

As always, StumbleUpon can also recommend some good Techdirt articles, too.

Filed Under: biology, flu, flu season, mosquito, vaccine, viral

Pharma Patents And Why Indonesia Is Hoarding Bird Flu Samples

Culture

from the this-isn't-good-for-health dept

We’ve pointed to plenty of examples concerning how pharmaceutical patents actually do more to hold back life-saving cures, and here’s another example. It’s actually a continuation of a story we wrote about a year and a half ago, about Indonesia’s decision to stop supplying bird flu samples to the World Health Organization, claiming it was worried that a big pharma would patent a drug based off of it, and Indonesia wouldn’t receive any of the benefit. The country has something of a point: as pharma companies have made various cures incredibly expensive in the past.

However, Indonesia is now taking this a step further, claiming “viral sovereignty” over the bird flu. In other words, it’s claiming that since the virus samples are found in the country, Indonesia owns the virus — and it’s fighting pretty much every attempt by others to do anything with the virus, sometimes using questionable claims such as one about how a US medical research facility is trying to use the virus not to create a cure, but to create biological weapons. It’s basing this claim of “viral sovereignty” on the same ridiculous patent rules that allow a country to claim “ownership” and patents over indigenous plants.

While there’s obviously a huge political component to this dispute, at the heart of the trouble is this idea of “ownership” of something like a plant, virus or drug — and that’s an idea that the US has been a huge supporter of, so it can hardly complain about Indonesia taking it to the logical conclusion. And, of course, that logical conclusion is the exact opposite of what supporters of pharma patents insist the system is designed to encourage. That is, thanks to this hoarding and claims of ownership, not nearly enough research is being done to try to create vaccines for bird flu. And, to make this even worse, it appears other countries are starting to consider “viral sovereignty,” as well — meaning that research into curing various diseases may grind to halt while various countries argue over who owns what.

Filed Under: flu, indonesia, patents, viral sovereignty, virus, who